BODIPY-based photosensitizers for cancer phototherapy: photophysical modulation, ROS-mediated cell death and phototheranostic applications
An integrated perspective on BODIPY photochemistry at the interface of tumor microenvironment engineering, regulated cell death (RCD), and cancer immunotherapy is presented, offering insights into the development of next-generation BODIPY-based phototheranostic platforms.